GlassScriptPhysician profile
David Antonio Rodriguez
NPI 1760525919
$4,837.33
in general payments reported to CMS, 2019-2025
41 companies · $940 in 2025
The $940 reported for 2025 was more than what 87% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $828 · 2020: $331 · 2021: $299 · 2022: $910 · 2023: $650 · 2024: $879 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $616.09 | 2022-2025 | Ubrelvy, Botox |
| Boston Scientific Corporation | $590.70 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $580.61 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $454.78 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $295.72 | 2019-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $285.12 | 2019-2025 | Relistor |
| Pfizer INC. | $202.52 | 2019-2024 | |
| Lundbeck LLC | $192.07 | 2022-2025 | Vyepti |
| Si-Bone, INC. | $163.46 | 2019-2025 | |
| Allergan, INC. | $148.24 | 2019-2022 | |
| Averitas Pharma INC. | $132.08 | 2023-2024 | Qutenza |
| Globus Medical, INC. | $111.09 | 2025 | Senza |
| Biotronik Nro, INC. | $101.46 | 2024-2025 | Prospera |
| Daiichi Sankyo INC. | $74.42 | 2019 | |
| Abbott Laboratories | $72.82 | 2023-2024 | Proclaim, Eterna |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.